The Dxcover Platform for Detection of Cancer
We have successfully completed two groundbreaking studies on earlier diagnosis of brain cancer, and we are currently developing our platform for the detection of commonly occurring cancers.
How does it work?
The Dxcover platform combines novel hardware with artificial intelligence algorithms to analyze a patient's blood and detect the presence or absence of disease.
SYMPTOMATIC
PATIENTS
BLOOD SERUM
INFRARED SPECTROSCOPY
DIAGNOSTIC ALGORITHM
DISEASE PREDICTION
Dxcover® Sample Slide
Sample is dropped onto a disposable Dxcover Slide and dried for analysis.
Dxcover® Autosampler
The autosampler unit enables rapid infrared analysis of the sample.
Dxcover® Platform
The Platform detects the presence or absence of disease in minutes.
A drop of blood serum is dried on a Dxcover® Slide and analyzed with infrared light. Data is captured from all the vital components, including the body’s response to disease. The Artificial Intelligence algorithm provides a result in minutes.
2023
A spectroscopic liquid biopsy for the earlier detection of multiple cancer types
JM Cameron, A Sala, G Antoniou, PM Brennan, HJB Butler, JJA Conn, S Connal, T Curran, MG Hegarty, RG Hardy, D Orringer, DS Palmer, BR Smith, MJ Baker
2020
Biofluid diagnostics by FTIR spectroscopy: A platform technology for cancer detection
A Sala, DJ Anderson, PM Brennan, HJ Butler, JM Cameron, ...
Cancer letters 477, 122-130
2022
Clinical Validation of a Spectroscopic Liquid Biopsy for Earlier Detection of Brain Cancer
JM Cameron, PM Brennan, G Antoniou, HJ Butler,...
Neurooncology Advances
2019
Development of high-throughput ATR-FTIR technology for rapid triage of brain cancer
HJ Butler, PM Brennan, JM Cameron, D Finlayson, MG Hegarty, ...
Nature Communications
2021
Early diagnosis of brain tumours using a novel spectroscopic liquid biopsy
PM Brennan, HJ Butler, L Christie, MG Hegarty...
Brain Communications
Key
Publications
